-The Hindu New Delhi: While observing that the Court could not encroach into policy matters of the government, the Delhi High Court has dismissed a public interest writ petition seeking directions to the Centre to make available generic medicines and medical treatment to the public at large at a reasonable cost. A Division Bench comprising Chief Justice G. Rohini and Justice R.S. Endlaw had earlier this week said that the Centre and...
More »SEARCH RESULT
Total Matching Records found : 55
Contaminated water leading to cancer, fear Indian villagers -Neeta Lal
-The Third Pole Villagers in India's Greater Noida district could be the latest victims of groundwater contamination with reports of increased cancer cases spurring investigations and concern about the situation elsewhere in the country The perils of groundwater contamination were again in the spotlight recently when media reports about drinking water causing cancer surfaced from five villages in an industrial belt on the outskirts of the Indian capital New Delhi. As medical experts...
More »SC agrees on urgent hearing of drug price plea
-The Telegraph The Supreme Court today agreed to take up "as early as possible" a plea challenging a recent NDA government decision that is alleged to have paved the way for a sharp rise in the prices of life-saving drugs. Petitioner Manohar Lal Sharma, a lawyer, has demanded a CBI probe into a September 22 government order that he says frees a list of medicines from pricing control. His public interest plea alleges...
More »Cancer drug price goes up from Rs 8,000 to Rs 1.08 lakh -Iftikhar Gilani
-DNA The Union government decision to decontrol prices of 108 drugs -- used to treat tuberculosis, AIDS, diabetes and heart ailments -- has jacked up their prices. In some cases, prices have seen an unbelievable rise. The price of Glivec, an anti-cancer tablet, for example, has risen from Rs 8,500 to Rs 1.08 lakh. Plavix, used to treat blood pressure and heart ailments, will cost Rs 1,615, against the earlier Rs 147. An...
More »Govt clips NPPA’s sweeping powers to control drug prices
-The Hindu Business Line Fate of 108 drugs brought under price control in July still unclear In a booster for pharmaceutical companies, the Government has ensured that the National Pharmaceutical Pricing Authority (NPPA) no longer enjoys sweeping powers to control drug prices. The NPPA on Tuesday withdrew the guidelines it issued on May 29 that allowed the Authority to control drug prices in public interest. Based on this, it had subsequently capped prices...
More »
